News

Tariffs won’t boost U.S. manufacturing — tax cuts will, Johnson & Johnson CEO says
For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...
Johnson & Johnson CEO warns US tariffs may disrupt drug supply
Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...
JNJ Earnings: Johnson & Johnson Posts Quarterly Beat and Raises Full-Year Sales Guidance
Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall Street ...
Fierce Pharma19h
As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations
J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.
Mayor Brandon Johnson responds to Trump's threats to withhold federal funding: "That is how terrorists behave"
"Trying to force your will to break the spirit of working people in order to have a conversation? That's terrorism. We're not ...
Johnson & Johnson (JNJ) Stands Firm as Recession-Resistant Tariff-Proof Anchor
With recession concerns circulating in the market, Johnson & Johnson (JNJ) stock could stabilize many portfolios. Since its founding in ...